Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 31 min 10 sec ago

Comstock outlines 2026 plan to drill 22 western Haynesville wells as it targets lower costs after $600M Pinnacle stake sale

Thu, 07/30/2026 - 20:14

Alignment Healthcare forecasts $5.20B-$5.23B 2026 revenue while raising membership outlook to 298k-301k

Thu, 07/30/2026 - 20:14

MannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for IPF - Slideshow

Thu, 07/30/2026 - 20:05

AlzChem Group AG 2026 Q2 - Results - Earnings Call Presentation

Thu, 07/30/2026 - 20:05

MPS signals 130% enterprise data growth floor for 2026 while expanding capacity beyond $6B

Thu, 07/30/2026 - 20:04

LSB Industries, Inc. 2026 Q2 - Results - Earnings Call Presentation

Thu, 07/30/2026 - 20:03

Pilgrim's Pride Corporation 2026 Q2 - Results - Earnings Call Presentation

Thu, 07/30/2026 - 20:03

West Fraser Timber Co. Ltd. 2026 Q2 - Results - Earnings Call Presentation

Thu, 07/30/2026 - 20:02

Hippo Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation

Thu, 07/30/2026 - 20:01

Subsea 7 S.A. 2026 Q2 - Results - Earnings Call Presentation

Thu, 07/30/2026 - 20:01

First Majestic Silver: The Silver Re-Rating Opportunity Returns (Rating Upgrade)

Thu, 07/30/2026 - 19:59

Western Union targets $50M run-rate cost reduction by year-end as it guides 2026 adjusted EPS to $1.25-$1.35

Thu, 07/30/2026 - 19:54

Xenia raises 2026 adjusted EBITDAre midpoint to $273M as RevPAR growth midpoint moves to 5.5%

Thu, 07/30/2026 - 19:54

Allegro outlines Q2 FY 2027 sales of $265M-$275M and EPS of $0.23-$0.26 as data center sales are set to more than double in FY 2027

Thu, 07/30/2026 - 19:54

Columbus McKinnon raises FY2027 outlook to $2.09B-$2.15B sales and $1.90-$2.10 adjusted EPS

Thu, 07/30/2026 - 19:54

Rimini Street expects Q3 2026 revenue of $110M-$112M while reiterating 4%-6% FY 2026 growth target

Thu, 07/30/2026 - 19:54

Phathom forecasts $310M-$325M 2026 revenue while planning Phase 3 as-needed GERD trial in Q4

Thu, 07/30/2026 - 19:44

Neurocrine raises 2026 INGREZZA sales guidance to $2.825B-$2.875B while integrating VYKAT XR

Thu, 07/30/2026 - 19:44

Apple: Why I'm Downgrading After A Solid Quarter (Downgrade)

Thu, 07/30/2026 - 19:43

Ferrari: Sorry For You, Mr. Market

Thu, 07/30/2026 - 19:34

Pages